The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Converting-Enzyme Inhibitors in the Treatment of Hypertension
Abstract
IN 1982, Vidt and colleagues reviewed the pharmacokinetics, mechanisms of action, and therapeutic usefulness of captopril, the first of a new class of antihypertensives, converting-enzyme inhibitors.1 2 3 A review of the literature from January 1983 through August 1987 (with use of MEDLARS) revealed more than 1200 reports on 16 other such inhibitors. This review will consider the six agents most frequently mentioned — captopril, enalapril, lisinopril, pentopril, ramipril, or alacepril — and their clinical use in hypertension, discussing only double-blind placebo washout comparison studies, except for tabulation of side effects.Biochemistry and PharmacokineticsAll the converting-enzyme inhibitors reviewed have a common . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ondetti, M. A., Rubin, B., & Cushman, D. W. (1977) · Science · doi:10.1126/science.191908 · Cited by 1,856
The Effects of Antihypertensive Therapy on the Quality of Life
Croog, S. H., Levine, S., Testa, M. A., Brown, B., Bulpitt, C. J., Jenkins, C. D., Klerman, G. L., & Williams, G. H. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606263142602 · Cited by 1,325
Self-citationChobanian, A. V. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380050029006 · Cited by 1,081
Hostetter, T. H., Rennke, H. G., & Brenner, B. M. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90490-9 · Cited by 796
Hricik, D. E., Browning, P. J., Kopelman, R., Goorno, W. E., Madias, N. E., & Dzau, V. J. (1983) · New England Journal of Medicine · doi:10.1056/nejm198302173080706 · Cited by 653
Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man
Gavras, H., Brunner, H. R., Turini, G. A., Kershaw, G. R., Tifft, C. P., Cuttelod, S., Gavras, I., Vukovich, R. A., & McKinstry, D. N. (1978) · New England Journal of Medicine · doi:10.1056/nejm197805042981803 · Cited by 602
A BRADYKININ‐POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARACA
FERREIRA, S. H. (1965) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1965.tb02091.x · Cited by 509
Effect of Captopril on Heavy Proteinuria in Azotemic Diabetics
Taguma, Y., Kitamoto, Y., Futaki, G., Ueda, H., Monma, H., Ishizaki, M., Takahashi, H., Sekino, H., & Sasaki, Y. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512263132601 · Cited by 412
Bjorck, S., Nyberg, G., Mulec, H., Granerus, G., Herlitz, H., & Aurell, M. (1986) · BMJ · doi:10.1136/bmj.293.6545.471 · Cited by 405
McGiff, J. C., Terragno, N. A., Malik, K. U., & Lonigro, A. J. (1972) · Circulation Research · doi:10.1161/01.res.31.1.36 · Cited by 352
Cited by
Wright, J. T. (2005) · JAMA · doi:10.1001/jama.293.13.1595 · Cited by 401
Angiotensin-converting enzyme inhibitor fetopathy.
Pryde, P. G., Sedman, A. B., Nugent, C. E., & Barr, M. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v391575 · Cited by 332
(2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.003 · Cited by 331
Elliott, W. J. (2006) · Yearbook of Cardiology · doi:10.1016/s0145-4145(07)70034-5 · Cited by 304
PUMPKIN-SEED OIL MODULATES THE EFFECT OF FELODIPINE AND CAPTOPRIL IN SPONTANEOUSLY HYPERTENSIVE RATS
ZUHAIR, H. A., ABD EL-FATTAH, A. A., & EL-SAYED, M. I. (2000) · Pharmacological Research · doi:10.1006/phrs.1999.0622 · Cited by 99
Metadata
- Authors
- Oates, J. A., Wood, A. J. J., & Williams, G. H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1988-12-08
- Volume
- 319
- Issue
- 23
- Pages
- 1517-1525
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2085147947
- Cited by
- 364
- References
- 60
- FWCI
- 23.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Converting-Enzyme Inhibitors in the Treatment of Hypertension. https://app.cochat.ai/papers/10.1056/nejm198812083192305
- The paper
- Oates, J. A., Wood, A. J. J., & Williams, G. H. (1988). Converting-Enzyme Inhibitors in the Treatment of Hypertension. New England Journal of Medicine. https://doi.org/10.1056/nejm198812083192305
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
